Age-related differences in Adriamycin-induced nephropathy

Pediatric Nephrology

Volumn 19, Issue 7, 2004, Pages 761-766

  Hahn, Hyewon ^a,b   Park, Young Seo ^b   Ha, Il Soo ^a   Cheong, Hae Il ^a   Choi, Yong ^a  

^a Seoul National University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Adriamycin; Age; Glomerulosclerosis hyalinosis; Nephropathy; Proteoglycan; Transforming growth factor 1

Indexed keywords

DECORIN; DOXORUBICIN; FIBROMODULIN; MESSENGER RNA; PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; GLOMERULOSCLEROSIS; HYALINE DEGENERATION; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FIBROSIS; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN URINE LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; URINARY EXCRETION;

AGE FACTORS; ANIMALS; DOXORUBICIN; FEMALE; KIDNEY DISEASES; MICE; MICE, INBRED BALB C;

EID: 3142784501     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-004-1487-z     Document Type: Article

References (35)

1. Wells RG (2000) Fibrogenesis. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279:G845-G850
2. Branton MH, Kopp JB (1999) TGF-beta and fibrosis. Microbes Infect 1:1349-1365
3. Okuda S, Languino LR, Ruoslahti E, Border WA (1990) Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. J Clin Invest 86:453-462
4. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta1. Nature 346:371-374
5. Yu L, Noble NA, Border WA (2002) Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol 2:177-181
6. Fukagawa M, Noda M, Shimizu T, Kurokawa K (1999) Chronic progressive interstitial fibrosis in renal disease - are there novel pharmacologic approaches? Nephrol Dial Transplant 14:2793-2795
7. Becker GJ, Hewitson TD (2000) The role of tubulointerstitial injury in chronic renal failure. Curr Opin Nephrol Hypertens 9:133-138
8. O'Donnell MP (2000) Renal tubulointerstitial fibrosis. Postgrad Med 108:159-172
9. Piek E, Heldin C-H, Dijke PT (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13:2105-2124
10. Rappolee DA, Brenner CA, Schultz R, Mark D, Werb Z (1988) Developmental expression of PDGF, TGF-alpha, and TGF-beta genes in preimplantation mouse embryos. Science 241:1823-1825
11. Zhao Y, Young SL, McIntosh JC, Steele MP, Silbajoris R (2000) Ontogeny and localization of TGF-beta type 1 receptor expression during lung development. Am J Physiol Lung Cell Mol Physiol 278:L1231-L1239
12. Thompson NL, Flanders KC, Smith JM, Ellingsworth LR, Roberts AB, Sporn MB (1989) Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol 108:661-669
13. Lane PH, Snelling DM, Babushkina-Patz N, Langer WJ (2001) Sex differences in the renal transforming growth factor-beta 1 system after puberty. Pediatr Nephrol 16:61-68
14. Okuda S, Motomura K, Sanai T, Onoyama K, Fujishima M (1988) High incidence of glomerular sclerosis in rats subjected to uninephrectomy at young age. Nephron 49:240-244
15. Sullivan KM, Lorenz HP, Meuli M, Lin RY, Adzick NS (1995) A model of scarless human fetal wound repair is deficient in transforming growth factor beta. J Pediatr Surg 30:198-202
16. Krummel TM, Michna BA, Thomas BL, Sporn MB, Nelson JM, Salzberg AM, Cohen IK, Diegelmann RF (1988) Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. Pediatr Surg 23:647-652
17. Hildebrand A, Romaris M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E (1992) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-beta. Biochem J 302:527-534
18. Schaefer L, Grone HJ, Raslik I, Robenek H, Ugorcakova J, Bundy S, Schaefer RM, Kresse H (2000) Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 58:1557-1568
19. Beanes SR, Dang C, Soo C, Wang Y, Urata M, Ting K, Fonkalsrud EW, Benhaim P, Hedrick MH, Atkinson JB, Lorenz HP (2001) Down-regulation of decorin, a transforming growth factor-beta modulator, is associated with scarless fetal wound healing. J Pediatr Surg 36:1666-1671
20. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K (2000) Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 157:423-433
21. Yamamoto T, Noble NA, Miller DE, Border WA (1994) Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927
22. Ha IS, Um EY, Jung HR, Park HW, Cheong HI, Choi Y (2002) Glucocorticoid diminishes vascular endothelial growth factor and exacerbates proteinuria in rats with mesangial proliferative glomerulonephritis. Am J Kidney Dis 39:1001-1010
23. Eikmans M, Baelde HJ, Heer E de, Bruijn JA (2001) Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies. Kidney Int 60:974-981
24. Ruiz-Torres MP, Bosch RJ, O'valle F, Moral RG del, Ramirez C, Masseroli M, Puyol MR, Puyol DR (1998) Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes. J Am Soc Nephrol 9:782-791
25. Cruz CI, Ruiz-Torres P, Moral RG del, Rodriguez-Puyol M, Rodriguez-Puyol D (2000) Age-related progressive renal fibrosis in rats and its prevention with ACE inhibitors and taurine. Am J Physiol Renal Physiol 278:F122-F129
26. Gagliano N, Arosio B, Santambrogio D, Balestrieri MR, Padoani G, Tagliabue J, Masson S, Vergani C, Annoni G (2000) Age-dependent expression of fibrosis-related genes and collagen deposition in rat kidney cortex. J Gerontol A Biol Sci Med Sci 55:B365-B372
27. Honkanen E, Teppo AM, Tornroth T, Groop PH, Gronhagen-Riska C (1997) Urinary transforming growth factor-beta1 in membranous glomerulonephritis. Nephrol Dial Transplant 12: 2562-2568
28. Ellis D, Forrest KYZ, Erbey J, Orchard TJ (1998) Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem 44:950-956
29. Matsumura M, Nishioka K, Fujii T, Yoshibayashi M, Nozaki K, Nakata Y, Temma S, Ueda T, Mikawa H (1994) Age-related acute adriamycin cardiotoxicity in mice. J Mol Cell Cardiol 26:899-905
30. Weinberg LE, Singal PK (1987) Refractory heart failure and age-related differences in adriamycin-induced myocardial changes in rats. Can J Physiol Pharmacol 65:1957-1965
31. Spiers DE, Candas V (1984) Relationship of skin surface area to body mass in the immature rat: a reexamination. J Appl Physiol 56:240-243
32. Burke BE, Mushlin PS, Cusack BJ, Olson SJ, Gambliel HA, Olson RD (2002) Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity. Cardiovasc Toxicol 2:41-51
33. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E (1992) Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361-364
34. Schaefer L, Macakova IR, Micegova M, Grone HJ, Schonherr E, Robenek H, Echtermeyer FG, Grassel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H (2002) Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 160:1181-1191
35. Colombo T, Donelli MG, Urso R, Dallarda S, Bartosek I, Guaitani A. (1989) Doxorubicin toxicity and pharmacokinetics in old and young rats. Exp Gerontol 24:159-171